Proud that my first piece as a Bulletin of the Atomic Scientists #Editorial #Fellow is now live! Category is: #DIY #COVID #Vaccines #pandemic TL;DR: It's not too long. Just read it. thebulletin.org/2021/10/do-it-…

This is a really personal story. It happens to be my story. I got a common, supposedly simple-to-treat #infection. Five rounds of treatment later, I've seen where our #antibiotics fail and how they can do more harm than good. Huge thanks to Patrick Skerrett STAT for hosting.

My second oped of the morning, this time for the US audience washingtonpost.com/outlook/2021/1…

Applications Now Open for the Emerging Leaders in Biosecurity Fellowship Class of 2022. centerforhealthsecurity.org/news/center-ne…

"We used to spend 2% of our GDP on research. Now we spend only 0.6%. This needs to change." - Michelle Rozo of @WHNSC #builtwithbiology

Very happy to have this manuscript out! It describes the outcomes of our first 20 patients with Mycobacterial infections treated with therapeutic phage. Graham Hatfull #NTM #CF academic.oup.com/cid/advance-ar…

Today marks the launch of Replay. Kicking off with a $55m seed #financing led by KKR & OMX_Ventures, Replay is a #genomewriting company reprogramming biology by writing & delivering #bigDNA. Follow Replay & read more here: replay.bio/news/replay-la…

We're LESS prepared for epidemics now than in 2019. I've recommended Kaiser Health News reporting on erosion of frontline capacities to many people recently. We've learned important lessons but if there is nobody to implement, we're lost. khn.org/news/tag/under…

Know any high school students curious about bioengineering? We will offer Stanford University's Intro. to Bioengineering for credit at no cost to students in Title 1-eligible schools. Info. session THIS Thursday: publicate.it/p/i23zEQAyQcXW… Grateful for retweets. National Education Equity Lab Jennbrophy.bsky.social

Applications are now open for the newest class of our Emerging Leaders in Biosecurity (ELBI) Fellowship! #ELBI inspires + connects the next generation of #biosecurity leaders and innovators. Learn how to apply thru Nov. 11: centerforhealthsecurity.org/our-work/emerg…

Please apply (and please share with people who might be interested)! Funding is not limited to US citizens, it is open to all interested in health security and public health.

We’re thrilled to announce our new Scientific Advisory Board of #GenomicMedicine and #CellTherapy experts. Learn more about our distinguished SAB members here:replay.bio/news/replay-es… #SAB #Appointments #GenomeWriting

Please join us in welcoming our new Scientific Advisory Board comprised of world-class experts across a broad range of areas of scientific importance in #genomicmedicine and cell therapy. To find out more about our distinguished #SAB members, click here: replay.bio/news/replay-es…

Read now: the #launch of our first #genetherapy product company, #Eudora in Endpoints News. Lei Lei Wu spoke to Replay Co-Founders AdrianWoolfson & Lachlan MacKinnon about how #retinaldiseases are the optimal starting point for our HSV platform, synHSV™: tinyurl.com/2ufx59za

Postdoc opportunities in my lab at the University of Pittsburgh! Come and join us! asmcareerconnections.org/job/postdoctor…

Today marks the launch of #Syena, our new #oncology-focused product company, formed with MD Anderson Cancer Center to pioneer a first-in-class T-Cell Receptor Natural Killer (TCR-NK) cell therapy. Read the announcement here: tinyurl.com/nhj4kuae #Syena #TCR-NK

Thanks to 1717 for the chance to talk about big DNA delivery with herpesviruses and gene therapy at Replay